Histologic Evaluation of Early Bone Regeneration Treated with Simvastatin Associated with Low-Level Laser Therapy
Jamilly Rodrigues de Miranda, DDS, MS/Isabela Goulart Gil Choi, DDS, MS/Maria Stella Moreira, DDS/Manoela Domingues Martins, DDS, PhD/Arthur Rodriguez Gonzalez Cortes, DDS, PhD/Marcelo Yoshimoto, DDS, PhD
PMID: 30892287
DOI: 10.11607/jomi.6990
Purpose: This histologic study aimed at assessing bone healing after treatment with simvastatin in association with low-level laser therapy (LLLT). Materials and Methods: Twenty-four male rats (Wistar) were submitted to surgery to create a bone defect of 5 mm in diameter in the parietal bone. These rats were randomly and equally divided into four treatment groups (n = 6): control (C), in which no treatment was performed; simvastatin (SIM), in which rats received daily subcutaneous doses of 2.5 mg/kg of simvastatin; LLLT, which was daily applied to the bone defect; and SIM-LLLT, in which both SIM and LLLT were daily applied. All laser irradiations were carried out with a 830-nm infrared diode laser (GaAlAs) with maximum output of 100 mW and a dose of 4 J, totaling 16 J per session. Rats were euthanized on the 12th postoperative day. Formalin-fixed paraffin-embedded bone samples were obtained and stained with hematoxylin-eosin (HE) and toluidine blue for optical microscope analysis. Degree of inflammation, new vascular formation, tissue repair, and osteoblastic activity were assessed. Results: Categorical analysis of the histologic slides revealed newly formed bone reaching the center of the surgical wound in two animals from the SIM group, two from the LLLT group, and three from the SIM-LLLT group. Greater new bone formation and a lower degree of inflammation were observed in the animals that had bone neoformation at the center of the defect, especially in the LLLT and SIM-LLLT groups. SIM and C groups presented greater angiogenesis than LLLT and SIM-LLLT. SIMLLLT therapy showed a statistically significant reduction in the degree of inflammation compared with the control group (P < .05). Conclusion: Within the limitations of this study, the present results suggest that a combination of simvastatin and low-level laser therapy may stimulate better bone formation.
| © 2022 Quintessence Publishing Co, Inc |
JOMI Home Current Issue Ahead of Print Archive Author Guidelines About |
Accepted Manuscripts Submission Form Submit Reprints Permission Advertising |
Quintessence Home Terms of Use Privacy Policy About Us Contact Us Help |
